NCIt definition : A recombinant human IgG1 monoclonal antibody (MoAb) directed against the tumor associated
antigen (TAA) epithelial cell adhesion molecule (EpCAM) with potential antitumor activity.
Adecatumumab binds to EpCAM, which may result in antibody-dependent cellular cytotoxicity
(ADCC) directed against EpCAM-expressing tumor cells. EpCAM (CD326), a cell surface
protein upregulated on many tumor cell types, promotes the proliferation, migration
and invasiveness of tumor cells; for some cancers, overexpression has been correlated
with decreased survival.;